{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:22:44Z","timestamp":1778714564339,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jneuroim.2013.11.001","type":"journal-article","created":{"date-parts":[[2013,11,10]],"date-time":"2013-11-10T04:15:35Z","timestamp":1384056935000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Scale up and safety parameters of antigen specific immunoadsorption of human anti-acetylcholine receptor antibodies"],"prefix":"10.1016","volume":"267","author":[{"given":"George","family":"Lagoumintzis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Zisimopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Trakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Grapsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Poulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.11.001_bb0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1526-0968.2000.004004275.x","article-title":"Therapeutic apheresis in myasthenia gravis","volume":"4","author":"Batocchi","year":"2000","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.transci.2005.11.001","article-title":"Quo vadis haemapheresis. Current developments in haemapheresis","volume":"34","author":"Borberg","year":"2006","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jca.2920040204","article-title":"Treatment of familial hypercholesterolemia by means of specific immunoadsorption","volume":"4","author":"Borberg","year":"1988","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0020","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1525-1594.1993.tb00609.x","article-title":"Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human blood","volume":"17","author":"Bosch","year":"1993","journal-title":"Artif. Organs"},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-2697(89)90191-7","article-title":"Viability measurements in mammalian cell systems","volume":"179","author":"Cook","year":"1989","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.jneuroim.2013.11.001_bb0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pharmthera.2006.03.005","article-title":"B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target","volume":"112","author":"Dalakas","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/039139880302600212","article-title":"Plasma exchange in the treatment of myasthenia gravis associated with thymoma","volume":"26","author":"Gogovska","year":"2003","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jim.2005.04.013","article-title":"Preparation of an immunoadsorbent coupled with a recombinant antigen to remove anti-acetylcholine receptor antibodies in abnormal serum","volume":"303","author":"Guo","year":"2005","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.jneuroim.2013.11.001_bb0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrn731","article-title":"Emerging structure of the nicotinic acetylcholine receptors","volume":"3","author":"Karlin","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb9000","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jca.2920070205","article-title":"Ten Years Experience With Therapeutic Apheresis in a Community Hospital","volume":"7","author":"Kornfeld","year":"1992","journal-title":"Journal of Clinical Apheresis"},{"issue":"15","key":"10.1016\/j.jneuroim.2013.11.001_bb0105","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1111\/j.1742-4658.2006.05363.x","article-title":"Expression and characterization of soluble forms of the extracellular domains of the beta, gamma and epsilon subunits of the human muscle acetylcholine receptor","volume":"273","author":"Kostelidou","year":"2006","journal-title":"FEBS J."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2013.11.001_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2007.07.018","article-title":"Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic auto-Abs: a combination of immunoadsorbents results in increased efficiency","volume":"190","author":"Kostelidou","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1525-1594.2007.00366.x","article-title":"Biocompatibility of an ovelavidin agarose adsorbent for extracorporeal removal of redundant radiopharmaceutical from the blood","volume":"31","author":"Kurkus","year":"2007","journal-title":"Artif. Organs"},{"issue":"5","key":"10.1016\/j.jneuroim.2013.11.001_bb0120","first-page":"1","article-title":"Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis","volume":"43","author":"Lagoumintzis","year":"2010","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.jneuroim.2013.11.001_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12028-009-9274-0","article-title":"Immunomodulatory therapies in neurologic critical care","volume":"12","author":"McDaneld","year":"2010","journal-title":"Neurocrit. Care."},{"issue":"46","key":"10.1016\/j.jneuroim.2013.11.001_bb0130","doi-asserted-by":"crossref","first-page":"47906","DOI":"10.1074\/jbc.M408440200","article-title":"Lipopolysaccharide-free heat shock protein 60 activates T cells","volume":"279","author":"Osterloh","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0135","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/clinchem\/45.8.1190","article-title":"Possible mechanism for in vitro complement activation in bloodand plasma samples: Futhan\/EDTA controls in vitro complement activation","volume":"45","author":"Pfeifer","year":"1999","journal-title":"Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2013.11.001_bb0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2007.06.014","article-title":"Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture","volume":"189","author":"Sideris","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0150","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(81)91213-7","article-title":"Application of specific extracorporeal removal of low density lipoproteinin familial hypercholesterolaemia","volume":"2","author":"Stoffel","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/jca.20134","article-title":"The new approach to assignment of ASFA Categories-introduction to the fourth special issue: clinical application of therapeutic apheresis","volume":"22","author":"Szczepiorkowski","year":"2007","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1526-0968.2001.00367.x","article-title":"Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor","volume":"5","author":"Takamori","year":"2001","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0165","series-title":"Therapeutic Hemapheresis","first-page":"43","article-title":"Apheresis in the treatment of myasthenia gravis","author":"Tindall","year":"1986"},{"key":"10.1016\/j.jneuroim.2013.11.001_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-065X.1998.tb01190.x","article-title":"Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor","volume":"163","author":"Tzartos","year":"1998","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.jneuroim.2013.11.001_bb0180","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s004150070149","article-title":"Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis","volume":"247","author":"Yeh","year":"2000","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2013.11.001_bb0185","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2013.11.001_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2008.06.002","article-title":"Antigen-specific apheresis of human anti-acetylcholine receptor auto-Abs from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains","volume":"200","author":"Zisimopoulou","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"201\u2013202","key":"10.1016\/j.jneuroim.2013.11.001_bb0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jneuroim.2008.06.020","article-title":"Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis","volume":"15","author":"Zisimopoulou","year":"2008","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281300310X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281300310X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:21:48Z","timestamp":1759047708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281300310X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S016557281300310X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.11.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scale up and safety parameters of antigen specific immunoadsorption of human anti-acetylcholine receptor antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}